canada clinical guidance

Pelvic inflammatory disease (PID)

A Canadian clinical summary of pelvic inflammatory disease (pid), with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.

Source and scope

This summary is bounded to the recommendations, population and decisions covered by STI-associated syndromes guide: Pelvic inflammatory disease. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:PHAC PID

Source-attributed clinical priorities

  • Maintain a low threshold for empiric treatment when pelvic pain and examination support PID and no better diagnosis is evident.
  • Test for gonorrhea, chlamydia, pregnancy and other relevant infections without delaying treatment.
  • Escalate pregnancy, severe illness, tubo-ovarian abscess, inability to tolerate oral therapy or an uncertain surgical diagnosis.
  • Treat empirically when the clinical threshold is met because delay can increase reproductive harm.
sources for this section:PHAC PID

Practical assessment and management workflow

1
Assess pregnancy, pelvic pain, bleeding, discharge, fever, STI exposure and severity.
2
Perform abdominal and pelvic examination with consent and collect STI, pregnancy and other indicated tests.
3
Start broad empiric treatment and arrange partner management without waiting for every result.
4
Review within a short interval for improvement and counsel about abstinence until treatment and partner care are complete.
sources for this section:PHAC PID

Safety, red flags and urgent escalation

  • Pregnancy, severe illness, tubo-ovarian abscess, vomiting or surgical diagnostic uncertainty may require admission.
  • Exclude ectopic pregnancy and appendicitis in acute pelvic pain.
  • Failure to improve promptly needs urgent reassessment and possible imaging or specialist care.
sources for this section:PHAC PID

Confirm the local pathway before acting

The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:PHAC PID

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:PHAC PID

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Public Health Agency of CanadaSTI-associated syndromes guide: Pelvic inflammatory diseaseaccessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.